Subscribe for the Newsletter

Mobile Navigation

Delivering Pluripotent Stems Cells Primed to Differentiate

Pluristyx

Pluristyx

Apr 26, 2022PAO-04-22-R250-71

On the Road to 50 States, Benjamin Fryer, a senior executive at Pluristxy, talks to Nigel about pluripotent stem cells and how the company speeds up the R&D process by delivering 'ready to differentiate' cells. 

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.